Aventis Behring is a Pharmaceutical Manufacturing company based in US .
| Website | http://www.aventisbehring.com |
| Revenue | $8.6 million |
| Employees | 28 (15 on RocketReach) |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Biotechnology, Life Sciences, Therapeutic Proteins, Immunology, Pharmaceutical Manufacturing, Blood Coagulation, Pharmaceutical Research, Drug Development, Inherited Disorders, Rare Diseases, Clinical Trials, Infection Prevention, Global Health, Vaccine Research, Health Care |
| Competitors | CSL Behring, Grifols, Takeda, Shire, Octapharma, Kedrion Biopharma, Baxter International Inc., ImmunoTek Bio Centers, LLC, Sangamo Therapeutics, Inc., Johnson & Johnson +38 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 2834 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 325 Companies, NAICS Code 541711 Companies, NAICS Code 54171 Companies |
Looking for a particular Aventis Behring employee's phone or email?
The Aventis Behring annual revenue was $8.6 million in 2026.
David Valentino is the Global Medical Director of Aventis Behring.
15 people are employed at Aventis Behring.
The NAICS codes for Aventis Behring are [32, 54, 541, 5417, 325, 541711, 54171].
The SIC codes for Aventis Behring are [283, 28, 2834].